TRH and TRH receptor system in the basolateral amygdala mediate stress-induced depression-like behaviors

Neuropharmacology

Volumn 97, Issue , 2015, Pages 346-356

  Choi, Juli ^a   Kim, Ji Eun ^a   Kim, Tae Kyung ^a   Park, Jin Young ^a   Lee, Jung Eun ^a   Kim, Hannah ^a   Lee, Eun Hwa ^a   Han, Pyung Lim ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Amygdala; Depression; Sociability; TRH; TRH receptor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEUROPEPTIDE; PROTIRELIN; PROTIRELIN RECEPTOR; SMALL INTERFERING RNA; TALTIRELIN; 1,3 BUTADIENE DERIVATIVE; ENZYME INHIBITOR; NITRILE; PSYCHOTROPIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR CHANGE; C57BL 6 MOUSE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FORCED SWIM TEST; IMMOBILIZATION STRESS; INBRED MOUSE STRAIN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RECEPTOR UPREGULATION; STEREOTACTIC PROCEDURE; UPREGULATION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMICALLY INDUCED; CHRONIC DISEASE; COMPLICATION; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; EXERCISE; GENETICS; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BASOLATERAL NUCLEAR COMPLEX; BUTADIENES; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MICE, INBRED C57BL; NITRILES; PSYCHOTROPIC DRUGS; RECEPTORS, THYROTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; RNA, SMALL INTERFERING; STRESS, PSYCHOLOGICAL; THYROTROPIN-RELEASING HORMONE;

EID: 84934753758     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.03.030     Document Type: Article

References (62)

1. A.F. Arnsten Stress signalling pathways that impair prefrontal cortex structure and function Nat. Rev. Neurosci. 10 2009 410 422
2. E.U. Bagriacik, M. Yaman, R. Haznedar, G. Sucak, and T. Delibasi TSH-induced gene expression involves regulation of self-renewal and differentiation-related genes in human bone marrow-derived mesenchymal stem cells J. Endocrinol. 212 2012 169 178
3. S.C. Bahls, and G.A. de Carvalho The relation between thyroid function and depression: a review Rev. Bras. Psiquiatr. 26 2004 41 49
4. C.M. Banki, G. Bissette, M. Arato, and C.B. Nemeroff Elevation of immunoreactive CSF TRH in depressed patients Am. J. Psychiatry 145 1988 1526 1531
5. E.B. Binder, and C.B. Nemeroff The CRF system, stress, depression and anxiety-insights from human genetic studies Mol. Psychiatry 15 2010 574 588
6. M. Boldrini, M.D. Underwood, J.J. Mann, and V. Arango Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides J. Psychiatr. Res. 42 2008 433 442
7. R. Bunevicius, and V. Matulevicius Short-lasting behavioural effects of thyrotropin-releasing hormone in depressed women: results of placebo-controlled study Psychoneuroendocrinology 18 1993 445 449
8. Y. Carrasquillo, and R.W. Gereau 4th Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception J. Neurosci. 27 2007 1543 1551
9. M.J. Chandley, K. Szebeni, A. Szebeni, J. Crawford, C.A. Stockmeier, G. Turecki, J.J. Miguel-Hidalgo, and G.A. Ordway Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder J. Psychiatry Neurosci. 38 2013 276 284
10. M.I. Chiamolera, and F.E. Wondisford Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism Endocrinology 150 2009 1091 1096
11. I.H. Cho, K.W. Lee, H.Y. Ha, and P.L. Han JNK/stress-activated protein kinase associated protein 1 is required for early development of telencephalic commissures in embryonic brains Exp. Mol. Med. 43 2011 462 470
12. R.H. Costa-e-Sousa, and A.N. Hollenberg Minireview: the neural regulation of the hypothalamic-pituitary-thyroid axis Endocrinology 153 2012 4128 4135
13. C.M. Daimon, P. Chirdon, S. Maudsley, and B. Martin The role of thyrotropin releasing hormone in aging and neurodegenerative diseases Am. J. Alzheimers Dis (Columbia) 1 1 2013
14. F. Duval, M.C. Mokrani, F.G. Lopera, T.S. Diep, H. Rabia, and S. Fattah Thyroid axis activity and suicidal behavior in depressed patients Psychoneuroendocrinology 35 2010 1045 1054
15. A.C. Felix-Ortiz, and K.M. Tye Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior J. Neurosci. 34 2014 586 595
16. E. Fliers, A. Kalsbeek, and A. Boelen Beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis Eur. J. Endocrinol. 171 2014 R197 R208
17. K.A. Gary, K.A. Sevarino, G.G. Yarbrough, A.J. Prange Jr., and A. Winokur The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics J. Pharmacol. Exp. Ther. 305 2003 410 416
18. M.E. Gilbert, J. Rovet, Z. Chen, and N. Koibuchi Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences Neurotoxicology 33 2012 842 852
19. M. Gutiérrez-Mariscal, P. de Gortari, C. López-Rubalcava, A. Martínez, and P. Joseph-Bravo Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety Psychoneuroendocrinology 33 2012 198 213
20. M.P. Hage, and S.T. Azar The link between thyroid function and depression J. Thyroid. Res. 2012 2012 590648
21. D.L. Helmreich, D.B. Parfitt, X.Y. Lu, H. Akil, and S.J. Watson Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress Neuroendocrinology 81 2005 183 192
22. I. Herpfer, and K. Lieb Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential CNS Drugs 19 2005 275 293
23. A. Hetzel, and J.A. Rosenkranz Distinct effects of repeated restraint stress on basolateral amygdala neuronal membrane properties in resilient adolescent and adult rats Neuropsychopharmacology 39 2014 2114 2130
24. H. Heuer, M.K. Schäfer, D. O'Donnell, P. Walker, and K. Bauer Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats J. Comp. Neurol. 428 2000 319 336
25. A. Holmes, M. Heilig, N.M. Rupniak, T. Steckler, and G. Griebel Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders Trends Pharmacol. Sci. 24 2003 580 588
26. R.T. Joffe, and M. Marriott Thyroid hormone levels and recurrence of major depression Am. J. Psychiatry 157 2000 1689 1691
27. R.T. Joffe Hormone treatment of depression Dialogues Clin. Neurosci. 13 2011 127 138
28. K.S. Kim, and P.L. Han Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters J. Neurosci. Res. 83 2006 497 507
29. K.S. Kim, K.W. Lee, I.S. Baek, C.M. Lim, V. Krishnan, J.K. Lee, E.J. Nestler, and P.L. Han Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior J. Neurochem. 107 2008 105 115
30. C. Kirkegaard, and J. Faber The role of thyroid hormones in depression Eur. J. Endocrinol. 138 1998 1 9
31. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
32. E. Kuteeva, T. Hökfelt, T. Wardi, and S.O. Ogren Galanin, galanin receptor subtypes and depression-like behaviour Cell. Mol. Life Sci. 65 2008 1854 1863
33. K.W. Lee, J.B. Kim, J.S. Seo, T.K. Kim, J.Y. Im, I.S. Baek, K.S. Kim, J.K. Lee, and P.L. Han Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress J. Neurochem. 108 2009 165 175
34. K. Li, T. Zhou, L. Liao, Z. Yang, C. Wong, F. Henn, R. Malinow, J.R. Yates 3rd, and H. Hu ßCaMKII in lateral habenula mediates core symptoms of depression Science 341 2013 1016 1020
35. G.M. MacQueen, S. Campbell, B.S. McEwen, K. Macdonald, S. Amano, R.T. Joffe, C. Nahmias, and L.T. Young Course of illness, hippocampal function, and hippocampal volume in major depression Proc. Natl. Acad. Sci. U. S. A. 100 2003 1387 1392
36. V. Madaan, and D.R. Wilson Neuropeptides: relevance in treatment of depression and anxiety disorders Drug News Perspect. 22 2009 319 324
37. M.E. Maheu, M.A. Davoli, G. Turecki, and N. Mechawar Amygdalar expression of proteins associated with neuroplasticity in major depression and suicide J. Psychiatr. Res. 47 2013 384 390
38. C.D. Mandyam The interplay between the hippocampus and amygdala in regulating aberrant hippocampal neurogenesis during protracted abstinence from alcohol dependence Front. Psychiatry 4 2013 61
39. J.J. Mann, Y.Y. Huang, M.D. Underwood, S.A. Kassir, S. Oppenheim, T.M. Kelly, A.J. Dwork, and V. Arango A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide Arch. Gen. Psychiatry 57 2000 729 738
40. L.B. Marangell, M.S. George, A.M. Callahan, T.A. Ketter, P.J. Pazzaglia, T.A. L'Herrou, G.S. Leverich, and R.M. Post Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients Arch. Gen. Psychiatry 54 1997 214 222
41. R. Massart, R. Raymond Mongeau, and L. Lanfumey Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression Philos. Trans. R. Soc. Lond. B Biol. Sci. 367 2012 2485 2494
42. J.C. Morales-Medina, Y. Dumont, and R. Quirion A possible role of neuropeptide Y in depression and stress Brain Res. 1314 2010 194 205
43. E.J. Nestler, and W.A. Carlezon Jr. The mesolimbic dopamine reward circuit in depression Biol. Psychiatry 59 2006 1151 1159
44. I.D. Neumann, and R. Landgraf Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors Trends Neurosci. 35 2012 649 659
45. E.L. Olivares, C. Silva-Almeida, F.M. Pestana, R. Sonoda-Côrtes, I.G. Araujo, N.C. Rodrigues, A.S. Mecawi, W.S. Côrtes, M.P. Marassi, L.C. Reis, and F.F. Rocha Social stress-induced hypothyroidism is attenuated by antidepressant treatment in rats Neuropharmacology 62 2012 446 456
46. C.A. Orsini, J.H. Kim, E. Knapska, and S. Maren Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction J. Neurosci. 31 2011 17269 17277
47. J.Y. Park, T.K. Kim, J. Choi, J.E. Lee, H. Kim, E.H. Lee, and P.L. Han Implementation of a two-dimensional behavior matrix to distinguish individuals with differential depression states in a rodent model of depression Exp. Neurobiol. 23 2014 1 9
48. K.A. Paschos, S. Veletza, and E. Chatzaki Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression CNS Drugs 23 2009 755 772
49. J. Patel, K. Landers, H. Li, R.H. Mortimer, and K. Richard Thyroid hormones and fetal neurological development J. Endocrinol. 209 2011 1 8
50. A.J. Prange Jr., P.P. Lara, I.C. Wilson, L.B. Alltop, and G.R. Breese Effects of tyrotropin-releasing-hormone in depression Lancet 2 1972 999 1002
51. J.L. Price, and W.C. Drevets Neurocircuitry of mood disorders Neuropsychopharmacology 35 2010 192 216
52. S.J. Russo, and E.J. Nestler The brain reward circuitry in mood disorders Nat. Rev. Neurosci. 14 2013 609 625
53. G.A. Scalabrino, N. Hogan, K.M. O'Boyle, G.R. Slator, D.J. Gregg, C.M. Fitchett, S.M. Draper, G.W. Bennett, P.M. Hinkle, K. Bauer, C.H. Williams, K.F. Tipton, and J.A. Kelly Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone Neuropharmacology 52 2007 1472 1481
54. T.P. Segerson, J. Kauer, H.C. Wolfe, H. Mobtaker, P. Wu, I.M. Jackson, and R.M. Lechan Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus Science 238 1987 78 80
55. J.S. Seo, J.Y. Park, J. Choi, T.K. Kim, J.H. Shin, J.K. Lee, and P.L. Han NADPH oxidase mediates depressive behavior induced by chronic stress in mice J. Neurosci. 32 2012 9690 9699
56. H.S.1 Shi, W.L. Zhu, J.F. Liu, Y.X. Luo, J.J. Si, S.J. Wang, Y.X. Xue, Z.B. Ding, J. Shi, and L. Lu PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3 Neuropsychopharmacology 37 2012 2671 2683
57. D. Sierra-Mercado, N. Padilla-Coreano, and G.J. Quirk Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear Neuropsychopharmacology 36 2011 529 538
58. F. Sotres-Bayon, D. Sierra-Mercado, E. Pardilla-Delgado, and G.J. Quirk Gating of fear in prelimbic cortex by hippocampal and amygdala inputs Neuron 76 2012 804 812
59. Y. Sun, X. Lu, and M.C. Gershengorn Thyrotropin-releasing hormone receptors - similarities and differences J. Mol. Endocrinol. 30 2003 87 97
60. Y. Sun, B. Zupan, B.M. Raaka, M. Toth, and M.C. Gershengorn TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes Neuropsychopharmacology 34 2008 1601 1608
61. R.O. Tasan, N.K. Nguyen, S. Weger, S.B. Sartori, N. Singewald, R. Heilbronn, H. Herzog, and G. Sperk The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression J. Neurosci. 30 2010 6282 6290
62. H. Zeng, B.A. Schimpf, A.D. Rohde, M.N. Pavlova, A. Gragerov, and J.E. Bergmann Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior Mol. Endocrinol. 21 2007 2795 2804